Definitive Healthcare Corp. (NASDAQ:DH) Short Interest Update

Definitive Healthcare Corp. (NASDAQ:DH - Get Free Report) was the recipient of a large drop in short interest in November. As of November 30th, there was short interest totalling 2,460,000 shares, a drop of 9.2% from the November 15th total of 2,710,000 shares. Based on an average daily volume of 425,400 shares, the days-to-cover ratio is currently 5.8 days. Approximately 5.3% of the company's stock are short sold.

Definitive Healthcare Price Performance

Shares of Definitive Healthcare stock traded down $0.01 on Friday, hitting $4.49. 210,901 shares of the company were exchanged, compared to its average volume of 721,441. Definitive Healthcare has a 1-year low of $3.19 and a 1-year high of $10.62. The company has a quick ratio of 2.49, a current ratio of 2.49 and a debt-to-equity ratio of 0.33. The stock has a market capitalization of $518.70 million, a price-to-earnings ratio of -1.45, a price-to-earnings-growth ratio of 3.29 and a beta of 1.40. The company has a 50-day moving average price of $4.41 and a 200 day moving average price of $4.72.

Insider Transactions at Definitive Healthcare

In other Definitive Healthcare news, insider William Moschella sold 45,000 shares of the business's stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total transaction of $211,500.00. Following the sale, the insider now owns 433,830 shares of the company's stock, valued at approximately $2,039,001. The trade was a 9.40 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 14.84% of the company's stock.

Hedge Funds Weigh In On Definitive Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of the company. Point72 DIFC Ltd increased its position in shares of Definitive Healthcare by 759.9% during the 3rd quarter. Point72 DIFC Ltd now owns 9,296 shares of the company's stock worth $42,000 after purchasing an additional 8,215 shares during the last quarter. Intech Investment Management LLC purchased a new position in Definitive Healthcare during the third quarter worth about $55,000. Bleakley Financial Group LLC acquired a new stake in shares of Definitive Healthcare during the third quarter valued at about $74,000. Glenmede Trust Co. NA lifted its holdings in shares of Definitive Healthcare by 41.1% in the 3rd quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company's stock worth $82,000 after acquiring an additional 5,362 shares during the last quarter. Finally, SG Americas Securities LLC acquired a new position in shares of Definitive Healthcare in the 3rd quarter worth approximately $84,000. 98.67% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the stock. Needham & Company LLC restated a "hold" rating on shares of Definitive Healthcare in a research report on Friday, November 8th. BTIG Research initiated coverage on Definitive Healthcare in a report on Tuesday, September 17th. They issued a "buy" rating and a $7.00 price objective for the company. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $5.81.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.